TECH - BIO-TECHNE Corp
59.88
-0.355 -0.593%
Share volume: 2,636,250
Last Updated: 03-13-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$60.24
-0.35
-0.01%
Fundamental analysis
63%
Profitability
71%
Dept financing
24%
Liquidity
75%
Performance
61%
Performance
5 Days
-4.80%
1 Month
-9.19%
3 Months
-21.38%
6 Months
-19.90%
1 Year
-15.92%
2 Year
-18.27%
Key data
Stock price
$59.88
DAY RANGE
$59.20 - $61.68
52 WEEK RANGE
$56.60 - $85.57
52 WEEK CHANGE
-$17.43
DIVIDEND
$0.08
EX-DIVIDEND DATE
02-14-2025
NEXT EARNINGS DATE
N/A
Company detail
CEO: Charles R. Kummeth
Region: US
Website: bio-techne.com
Employees: 3,000
IPO year: 1992
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing
Region: US
Website: bio-techne.com
Employees: 3,000
IPO year: 1992
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services. Protein Sciences segment provides biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy. Diagnostics and Genomics segment provides diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market.
Recent news